Fhit, a member of the histidine triad superfamily of nucleotide-binding pro
teins, binds and cleaves diadenosine polyphosphates and functions as a tumo
r suppressor in human epithelial cancers. Function of Fhit in tumor suppres
sion does not require diadenosine polyphosphate cleavage but correlates wit
h the ability to form substrate complexes. As diadenosine polyphosphates ar
e at lower cellular concentrations than mononucleotides, we sought to quant
ify interactions between Fhit and competitive inhibitors with the use of di
adenosine polyphosphate analogs containing fluorophores in place of one nuc
leoside. Appp-S-(7-diethylamino-4-methyl-3-(4-succinimidylphenyl)) coumarin
(ApppAMC), Appp-S-(4-4-difluoFo-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacine
-3-yl) methylaminoacetyl (ApppBODIPY), and GpppBODIPY, synthesized in high
yield, are effective Fhit substrates, producing AMP or GIMP plus fluorophor
e diphosphates. GpppBODIPY cleavage is accompanied by a 5.4-fold increase i
n fluorescence because BODIPY fluorescence is quenched by stacking with gua
nine. Titration of unlabeled diadenosine polyphosphates, inorganic pyrophos
phate, mononucleotides, and inorganic phosphate into fluorescent assays pro
vided values of K-m and K-I as competitive inhibitors. The data indicate th
at Fhit discriminates between good substrates via k(cat) and against cellul
ar competitors in equilibrium binding terms. Surprisingly, pyrophosphate co
mpetes better than purine mononucleotides.